BIOMAT Database Logo BIOMAT Database Logo

PAC1 receptor-deficient mice display impaired insulinotropic response to glucose and reduced glucose tolerance. 2000

F Jamen, and K Persson, and G Bertrand, and N Rodriguez-Henche, and R Puech, and J Bockaert, and B Ahrén, and P Brabet
Unité Propre de Recherche (UPR9023) Centre National de la Recherche Scientifique, Montpellier, France.

Pituitary adenylate cyclase-activating polypeptide (PACAP) is a ubiquitous neuropeptide of the vasoactive intestinal peptide (VIP) family that potentiates glucose-stimulated insulin secretion. Pancreatic beta cells express two PACAP receptor subtypes, a PACAP-preferring (PAC1) and a VIP-shared (VPAC2) receptor. We have applied a gene targeting approach to create a mouse lacking the PAC1 receptor (PAC1(-/-)). These mice were viable and normoglycemic, but exhibited a slight feeding hyperinsulinemia. In vitro, in the isolated perfused pancreas, the insulin secretory response to PACAP was reduced by 50% in PAC1(-/-) mice, whereas the response to VIP was unaffected. In vivo, the insulinotropic action of PACAP was also acutely reduced, and the peptide induced impairment of glucose tolerance after an intravenous glucose injection. This demonstrates that PAC1 receptor is involved in the insulinotropic action of the peptide. Moreover, PAC1(-/-) mice exhibited reduced glucose-stimulated insulin secretion in vitro and in vivo, showing that the PAC1 receptor is required to maintain normal insulin secretory responsiveness to glucose. The defective insulinotropic action of glucose was associated with marked glucose intolerance after both intravenous and gastric glucose administration. Thus, these results are consistent with a physiological role for the PAC1 receptor in glucose homeostasis, notably during food intake.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008817 Mice, Mutant Strains Mice bearing mutant genes which are phenotypically expressed in the animals. Mouse, Mutant Strain,Mutant Mouse Strain,Mutant Strain of Mouse,Mutant Strains of Mice,Mice Mutant Strain,Mice Mutant Strains,Mouse Mutant Strain,Mouse Mutant Strains,Mouse Strain, Mutant,Mouse Strains, Mutant,Mutant Mouse Strains,Mutant Strain Mouse,Mutant Strains Mice,Strain Mouse, Mutant,Strain, Mutant Mouse,Strains Mice, Mutant,Strains, Mutant Mouse
D009479 Neuropeptides Peptides released by NEURONS as intercellular messengers. Many neuropeptides are also hormones released by non-neuronal cells. Neuropeptide
D010179 Pancreas A nodular organ in the ABDOMEN that contains a mixture of ENDOCRINE GLANDS and EXOCRINE GLANDS. The small endocrine portion consists of the ISLETS OF LANGERHANS secreting a number of hormones into the blood stream. The large exocrine portion (EXOCRINE PANCREAS) is a compound acinar gland that secretes several digestive enzymes into the pancreatic ductal system that empties into the DUODENUM.
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D011979 Receptors, Pituitary Hormone Cell surface proteins that bind pituitary hormones with high affinity and trigger intracellular changes influencing the behavior of cells. Since many pituitary hormones are also released by neurons as neurotransmitters, these receptors are also found in the nervous system. Pituitary Hormone Receptors,Receptors, Pituitary Hormones,Pituitary Hormones Receptors
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D005260 Female Females
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor

Related Publications

F Jamen, and K Persson, and G Bertrand, and N Rodriguez-Henche, and R Puech, and J Bockaert, and B Ahrén, and P Brabet
The insulin response to gastric glucose is reduced in PAC1 and GRP receptor gene deleted mice.
March 2006, Nutrition, metabolism, and cardiovascular diseases : NMCD,
F Jamen, and K Persson, and G Bertrand, and N Rodriguez-Henche, and R Puech, and J Bockaert, and B Ahrén, and P Brabet
Markedly reduced chronic nociceptive response in mice lacking the PAC1 receptor.
July 2001, Neuroreport,
F Jamen, and K Persson, and G Bertrand, and N Rodriguez-Henche, and R Puech, and J Bockaert, and B Ahrén, and P Brabet
PCSK9-deficient mice exhibit impaired glucose tolerance and pancreatic islet abnormalities.
February 2010, FEBS letters,
F Jamen, and K Persson, and G Bertrand, and N Rodriguez-Henche, and R Puech, and J Bockaert, and B Ahrén, and P Brabet
INSL5-deficient mice display an alteration in glucose homeostasis and an impaired fertility.
October 2012, Endocrinology,
F Jamen, and K Persson, and G Bertrand, and N Rodriguez-Henche, and R Puech, and J Bockaert, and B Ahrén, and P Brabet
Resistin knockout mice exhibit impaired adipocyte glucose-dependent insulinotropic polypeptide receptor (GIPR) expression.
February 2013, Diabetes,
F Jamen, and K Persson, and G Bertrand, and N Rodriguez-Henche, and R Puech, and J Bockaert, and B Ahrén, and P Brabet
G-protein-coupled receptor GPR21 knockout mice display improved glucose tolerance and increased insulin response.
February 2012, Biochemical and biophysical research communications,
F Jamen, and K Persson, and G Bertrand, and N Rodriguez-Henche, and R Puech, and J Bockaert, and B Ahrén, and P Brabet
Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development.
June 1998, Neuron,
F Jamen, and K Persson, and G Bertrand, and N Rodriguez-Henche, and R Puech, and J Bockaert, and B Ahrén, and P Brabet
Elevated plasma glucose-dependent insulinotropic polypeptide associates with hyperinsulinemia in impaired glucose tolerance.
July 2004, Diabetes care,
F Jamen, and K Persson, and G Bertrand, and N Rodriguez-Henche, and R Puech, and J Bockaert, and B Ahrén, and P Brabet
Impaired glucose tolerance in copper-deficient rats.
May 1983, The Journal of nutrition,
F Jamen, and K Persson, and G Bertrand, and N Rodriguez-Henche, and R Puech, and J Bockaert, and B Ahrén, and P Brabet
Mice deficient for all PIM kinases display reduced body size and impaired responses to hematopoietic growth factors.
July 2004, Molecular and cellular biology,
Copied contents to your clipboard!